{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:40:32Z","timestamp":1794436832319,"version":"4.9.1"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460465"],"award-info":[{"award-number":["82460465"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005329","name":"Natural Science Foundation of Guizhou Province","doi-asserted-by":"publisher","award":["ZK[2024]346"],"award-info":[{"award-number":["ZK[2024]346"]}],"id":[{"id":"10.13039\/501100005329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.critrevonc.2026.105193","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T07:58:50Z","timestamp":1770364730000},"page":"105193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Bridging the translational gap in HNSCC immunotherapy: From resistance mechanisms to high-fidelity preclinical models"],"prefix":"10.1016","volume":"220","author":[{"given":"Shasha","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3842-4007","authenticated-orcid":false,"given":"Xiaoxia","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105193_bib1","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.tcb.2014.06.001","article-title":"Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment","volume":"24","author":"Ackerman","year":"2014","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.critrevonc.2026.105193_bib2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Network CGA: Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","author":"Anon","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105193_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/bs.mcb.2024.05.007","article-title":"Tumor slice culture system for ex vivo immunotherapy studies","volume":"189","author":"Arrizabalaga","year":"2024","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.critrevonc.2026.105193_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12865-017-0209-9","article-title":"Long-term leukocyte reconstitution in NSG mice transplanted with human cord blood hematopoietic stem and progenitor cells","volume":"18","author":"Audig\u00e9","year":"2017","journal-title":"BMC Immunol."},{"key":"10.1016\/j.critrevonc.2026.105193_bib5","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2026.105193_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/0300985820948822","article-title":"Human CD34(+) hematopoietic stem cell-engrafted NSG mice: morphological and immunophenotypic features","volume":"58","author":"Bl\u00fcmich","year":"2021","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105193_bib7","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.drudis.2009.09.014","article-title":"Surrogate approaches in development of monoclonal antibodies","volume":"14","author":"Bornstein","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.critrevonc.2026.105193_bib8","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1039\/D5LC00062A","article-title":"Patient-derived organotypic tumor spheroids, tumoroids, and organoids: advancing immunotherapy using state-of-the-art 3D tumor model systems","volume":"25","author":"Bozym","year":"2025","journal-title":"Lab Chip"},{"key":"10.1016\/j.critrevonc.2026.105193_bib9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.critrevonc.2026.105193_bib10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.critrevonc.2026.105193_bib11","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2026.105193_bib12","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2026.105193_bib13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nrc.2016.140","article-title":"Interrogating open issues in cancer precision medicine with patient-derived xenografts","volume":"17","author":"Byrne","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105193_bib14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fcell.2019.00052","article-title":"Heterogeneity of the head and neck squamous cell carcinoma immune landscape and its impact on immunotherapy","volume":"7","author":"Canning","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.critrevonc.2026.105193_bib15","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cell.2017.03.023","article-title":"Physiologic medium rewires cellular metabolism and reveals uric acid as an endogenous inhibitor of UMP synthase","volume":"169","author":"Cantor","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105193_bib16","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1158\/0008-5472.CAN-15-0727","article-title":"Maintaining tumor heterogeneity in patient-derived tumor xenografts","volume":"75","author":"Cassidy","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105193_bib17","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1038\/s41467-018-06654-8","article-title":"TGF-\u03b2-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure","volume":"9","author":"Chakravarthy","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105193_bib18","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1038\/s41467-018-06654-8","article-title":"TGF-\u03b2-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure","volume":"9","author":"Chakravarthy","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105193_bib19","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105193_bib20","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.critrevonc.2026.105193_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105193_bib22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1715715","article-title":"Head and neck cancer","volume":"382","author":"Chow","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2026.105193_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar3593","article-title":"Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy","volume":"362","author":"Cristescu","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105193_bib24","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1239005","article-title":"LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma","volume":"5","author":"Deng","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.critrevonc.2026.105193_bib25","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1158\/2159-8290.CD-18-1522","article-title":"Oral mucosal organoids as a potential platform for personalized cancer therapy","volume":"9","author":"Driehuis","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105193_bib26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1152\/physiol.00036.2016","article-title":"Modeling physiological events in 2D vs. 3D cell culture","volume":"32","author":"Duval","year":"2017","journal-title":"Physiology"},{"key":"10.1016\/j.critrevonc.2026.105193_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2025.107536","article-title":"Prediction of clinical outcomes of immune checkpoint inhibitors in advanced head and neck cancer directly from histopathology slides using inferred transcriptomics","volume":"168","author":"Elia","year":"2025","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105193_bib28","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2026.105193_bib29","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1158\/0008-5472.CAN-19-3158","article-title":"NOX4 inhibition potentiates immunotherapy by overcoming cancer-associated fibroblast-mediated CD8 T-cell exclusion from tumors","volume":"80","author":"Ford","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105193_bib30","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98811","article-title":"Frameshift events predict anti-PD-1\/L1 response in head and neck cancer","volume":"3","author":"Hanna","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.critrevonc.2026.105193_bib31","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1200\/JCO.21.02508","article-title":"Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: updated results of the phase III KEYNOTE-048 study","volume":"41","author":"Harrington","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105193_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa1260","article-title":"Immunological mechanisms of the antitumor effects of supplemental oxygenation","volume":"7","author":"Hatfield","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105193_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","article-title":"Top 10 challenges in cancer immunotherapy","volume":"52","author":"Hegde","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2026.105193_bib34","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-15-2402","article-title":"A three-dimensional organoid culture system derived from human glioblastomas recapitulates the hypoxic gradients and cancer stem cell heterogeneity of tumors found in vivo","volume":"76","author":"Hubert","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105193_bib35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1479-5876-11-110","article-title":"Origin of the vasculature supporting growth of primary patient tumor xenografts","volume":"11","author":"Hylander","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105193_bib36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.critrevonc.2026.105193_bib37","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.celrep.2018.10.004","article-title":"Patient-derived xenografts for prognostication and personalized treatment for head and neck squamous cell carcinoma","volume":"25","author":"Karamboulas","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.critrevonc.2026.105193_bib38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3892\/ol.2021.12644","article-title":"Macrophage CCL22 expression promotes lymphangiogenesis in patients with tongue squamous cell carcinoma via IL-4\/STAT6 in the tumor microenvironment","volume":"21","author":"Kimura","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2026.105193_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.106012","article-title":"The mouse oral carcinoma (MOC) model: A 10-year retrospective on model development and head and neck cancer investigations","volume":"132","author":"Kono","year":"2022","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105193_bib40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.immuni.2016.01.014","article-title":"CD45 phosphatase inhibits STAT3 transcription factor activity in myeloid cells and promotes tumor-associated macrophage differentiation","volume":"44","author":"Kumar","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2026.105193_bib41","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.4049\/jimmunol.1000901","article-title":"Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells","volume":"185","author":"Lechner","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105193_bib42","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nm.3585","article-title":"Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture","volume":"20","author":"Li","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2026.105193_bib43","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1158\/1078-0432.CCR-16-2819","article-title":"Suppression of lymphocyte functions by plasma exosomes correlates with disease activity in patients with head and neck cancer","volume":"23","author":"Ludwig","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105193_bib44","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.csbj.2019.07.009","article-title":"Correlate the TP53 mutation and the HRAS mutation with immune signatures in head and neck squamous cell cancer","volume":"17","author":"Lyu","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.critrevonc.2026.105193_bib45","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89829","article-title":"The head and neck cancer immune landscape and its immunotherapeutic implications","volume":"1","author":"Mandal","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.critrevonc.2026.105193_bib46","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105193_bib47","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105193_bib48","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/onc.2015.94","article-title":"XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer","volume":"35","author":"Morton","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105193_bib49","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","article-title":"Prevention of allogeneic fetal rejection by tryptophan catabolism","volume":"281","author":"Munn","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105193_bib50","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nm1609","article-title":"Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer","volume":"13","author":"Nagaraj","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2026.105193_bib51","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","article-title":"Organoid modeling of the tumor immune microenvironment","volume":"175","author":"Neal","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105193_bib52","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","article-title":"Organoid modeling of the tumor immune microenvironment","volume":"175","author":"Neal","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105193_bib53","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fcgamma receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105193_bib54","doi-asserted-by":"crossref","first-page":"13132","DOI":"10.1073\/pnas.0605251103","article-title":"A2A adenosine receptor protects tumors from antitumor T cells","volume":"103","author":"Ohta","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.critrevonc.2026.105193_bib55","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1158\/2159-8290.CD-18-0044","article-title":"Mouse models for cancer immunotherapy research","volume":"8","author":"Olson","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105193_bib56","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1158\/1078-0432.CCR-14-0205","article-title":"A surprising cross-species conservation in the genomic landscape of mouse and human oral cancer identifies a transcriptional signature predicting metastatic disease","volume":"20","author":"Onken","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105193_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay2574","article-title":"Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients","volume":"11","author":"Ooft","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105193_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay2574","article-title":"Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients","volume":"11","author":"Ooft","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105193_bib59","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1158\/0008-5472.CAN-15-3121","article-title":"Upregulated glucose metabolism correlates inversely with CD8+ T-cell infiltration and survival in squamous cell carcinoma","volume":"76","author":"Ottensmeier","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105193_bib60","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12943-019-0983-5","article-title":"Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review","volume":"18","author":"Peltanova","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105193_bib61","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.freeradbiomed.2017.10.003","article-title":"Limitations of oxygen delivery to cells in culture: an underappreciated problem in basic and translational research","volume":"113","author":"Place","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.critrevonc.2026.105193_bib62","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1182\/blood-2006-06-031856","article-title":"L-arginine availability regulates T-lymphocyte cell-cycle progression","volume":"109","author":"Rodriguez","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2026.105193_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010232","article-title":"Ex-vivo treatment of tumor tissue slices as a predictive preclinical method to evaluate targeted therapies for patients with renal carcinoma","volume":"12","author":"Roelants","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105193_bib64","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105193_bib65","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1172\/JCI45817","article-title":"Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors","volume":"122","author":"Salmon","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2026.105193_bib66","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2018.09.035","article-title":"A paradigm shift in cancer immunotherapy: from enhancement to normalization","volume":"175","author":"Sanmamed","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105193_bib67","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1158\/0008-5472.CAN-14-3510","article-title":"Nivolumab and urelumab enhance antitumor activity of human T lymphocytes engrafted in Rag2-\/-IL2R\u03b3null immunodeficient mice","volume":"75","author":"Sanmamed","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105193_bib68","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nri3311","article-title":"Humanized mice for immune system investigation: progress, promise and challenges","volume":"12","author":"Shultz","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105193_bib69","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1073\/pnas.0908801107","article-title":"Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis","volume":"107","author":"Stagg","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.critrevonc.2026.105193_bib70","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2026.105193_bib71","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrclinonc.2012.61","article-title":"Patient-derived tumour xenografts as models for oncology drug development","volume":"9","author":"Tentler","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105193_bib72","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","article-title":"TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance","volume":"8","author":"Thomas","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2026.105193_bib73","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s41199-020-00056-4","article-title":"Preclinical models of head and neck squamous cell carcinoma for a basic understanding of cancer biology and its translation into efficient therapies","volume":"5","author":"Tinhofer","year":"2020","journal-title":"Cancers Head. Neck"},{"key":"10.1016\/j.critrevonc.2026.105193_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-61684-1","article-title":"Transcriptomic analysis-guided assessment of precision-cut tumor slices (PCTS) as an ex-vivo tool in cancer research","volume":"14","author":"Trivedi","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105193_bib75","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm934","article-title":"Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase","volume":"9","author":"Uyttenhove","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2026.105193_bib76","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1172\/JCI60083","article-title":"STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients","volume":"123","author":"Vasquez-Dunddel","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2026.105193_bib77","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41597-023-02611-3","article-title":"Characterization of immune microenvironment in patients with HPV-positive and negative head and neck cancer","volume":"10","author":"Wang","year":"2023","journal-title":"Sci. Data"},{"key":"10.1016\/j.critrevonc.2026.105193_bib78","article-title":"Suppression of MCP-1, IFN-\u03b3 and IL-6 production of HNSCC ex vivo by pembrolizumab added to docetaxel and cisplatin (TP) exceeding those of TP alone is linked to improved survival","volume":"15","author":"Wellhausen","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105193_bib79","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41698-021-00168-1","article-title":"Patient-derived organoids as a predictive biomarker for treatment response in cancer patients","volume":"5","author":"Wensink","year":"2021","journal-title":"NPJ Precis Oncol."},{"key":"10.1016\/j.critrevonc.2026.105193_bib80","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41698-021-00168-1","article-title":"Patient-derived organoids as a predictive biomarker for treatment response in cancer patients","volume":"5","author":"Wensink","year":"2021","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105193_bib81","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/biostatistics\/kxx069","article-title":"Estimation of clinical trial success rates and related parameters","volume":"20","author":"Wong","year":"2019","journal-title":"Biostatistics"},{"key":"10.1016\/j.critrevonc.2026.105193_bib82","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00005-018-0506-x","article-title":"Humanized mice as unique tools for human-specific studies","volume":"66","author":"Yong","year":"2018","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.critrevonc.2026.105193_bib83","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.4049\/jimmunol.1501293","article-title":"Human head and neck squamous cell carcinoma-associated semaphorin 4D induces expansion of myeloid-derived suppressor cells","volume":"196","author":"Younis","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105193_bib84","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1158\/0008-5472.CAN-24-0067","article-title":"DAZAP1 phase separation regulates mitochondrial metabolism to facilitate invasion and metastasis of oral squamous cell carcinoma","volume":"84","author":"Zhang","year":"2024","journal-title":"Cancer Res."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826000806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826000806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:24:30Z","timestamp":1778581470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826000806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":84,"alternative-id":["S1040842826000806"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105193","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging the translational gap in HNSCC immunotherapy: From resistance mechanisms to high-fidelity preclinical models","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105193"}}